Skip to main content
Stock For Long Term Gains 

GREENLAM INDUSTRIES LTD (538979 & NSE) (393)


Greenlam Industries Limited manufactures and sells laminates, decorative veneers, and their allied products in India and internationally. The company operates through Laminate & Allied Products, and Veneered & Allied Products segments. The company offers laminates for kid’s bedroom, wardrobe, cupboard, restroom, and commercial spaces; decorative laminates for kitchen, living room, office, or commercial spaces; compact laminates for restroom cubicles, partitions, lockers, worktops, kid's furniture, and lab and school furniture; interior and exterior laminates; digital laminates for wardrobe, study table, kitchen, etc.; and post forming laminates for shutters, counter tops, furniture tops, etc. It also provides switch board panels for use in homes and offices; low maintenance liner grade laminates; fire retardant laminates for fire prone areas, such as kitchens, etc., as well as for cinema halls, schools, or hotels; green and HD gloss, and green touch laminates; and chalk and marker grade laminates. In addition, the company offers decorative veneers, which are used in residential and commercial fittings; engineered wood flooring products; and engineered doors and door frames. The company offers its products under the Greenlam, Greenlam Compact Laminate, and Mikasa brands. The company was incorporated in 2013 and is based in New Delhi, India. Promoters hold 55.09%, FIIs hold 12.37%, DIIs hold 7.59% while the investing public holds 24.95% stake in the company.For Q1FY16, it has reported net sales of Rs.217crore & profit of Rs.6.38crore.Q1FY16 EPS stood at Rs.2.64. Company is setting up 2 plants. One is located at Rajasthan & second is located at Himachal Pradesh. Construction work starts at both plants. Stock is looking explosive for investment. One can watch this stock keeping stop loss of 360. On the upper side stock will zoom up to Rs.450 level, while it can zoom up to its 52 week’s high rate of Rs.575 in long term…

Comments

Post a Comment

Popular posts from this blog

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News*   *TCI FINANCE LTD (501242 & NSE) (31)*   Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc.   The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL   The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services.   *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...
1 comment
Read more

Danlaw Technologies India Ltd: For multi-bagger gains (BSE Code: 532329) (CMP: Rs. 60.75) (FV: Rs.10)

The earnings season so far has been weak and worries over domestic growth continue to weigh on the market sentiment which has led the markets back on the downward path.. A value investor, however, need not worry about the broad markets as value stocks perform better and post good results. One such value-pick is Danlaw Technologies India Ltd. (DTIL). Company background: DTIL is the offshore technology and product development center of its parent company - Danlaw Incorporated, founded by Mr. Raju Dandu and Mr. Lloyd Lawrence in Michigan, USA in 1984. DTIL’s mission is to provide high quality services and products in Automotive Electronics, develop R&D driven Signal Processing technologies for communication and control, configure solutions and provide exceptional Information Technology (IT) services in the areas of education, health, banking and e-governance and provide world-class products and solutions for secured access through biometric access control technologies with intellige...
1 comment
Read more

Some Opportunities Are left in Pharma Sector

Torrent Pharmaceuticals  reported impressive 75% growth in revenues and profit in the first quarter of FY 2016. The sterling performance was driven by the launch of new product in the US market, which has limited competition at present. The focus is on the therapeutic segments of cardiovascular and CNS. There is presence in gastro-intestinal, diabetology, anti-infective, pain management, nephrology, oncology, gynecology and pediatric segments as well. The manufacturing plants for formulations and bulk drugs have been approved by authorities of several regulated and semi-regulated markets such as the US, the UK, Brazil, Germany, Australia and South Africa. Capacity will increase almost 100% once the new plant at Dahej in Gujarat becomes operational. The plant will be one of the largest pharmaceuticals manufacturing facilities in the country at a single location. The unit will primarily cater to the key regulated markets of the US and Europe. Approval from regulators such...
Post a Comment
Read more